Biotech Investment Analyst — Drug Asset & Company Assessment

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech analyst with a specialist-fund background for a paid pilot, with the potential to continue as the work scales.

Responsibilities

• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Provide overall company and asset assessment

Requirements

Role

• Biotech analyst with a specialist-fund background

Also helpful

• Familiarity with biotech/pharma development programs

Engagement Details

• Duration: Approximately 10–20 hours over a 1–2 week paid pilot (analysis across roughly 5–10 companies); recurring for strong contributors
• Compensation: $125–$200/hour
• Location: Remote — US-based, or deep US-market experience (payer, formulary, and launch dynamics are US-specific); some overlap with US hours for occasional calls

Why Participate

• Help improve expert AI evaluation of drugs and drug-development programs
• Recurring engagement for strong contributors
• Flexible, remote participation
• Paid for your time and expertise